Trinity Biotech PLC reports results for the quarter ended September 30 - Earnings Summary

Reuters
2024-11-15
Trinity Biotech <a href="https://laohu8.com/S/PLC">PLC</a> reports results for the quarter ended September 30 - Earnings Summary
  • Trinity Biotech PLC TRIB.OQ reported a quarterly adjusted loss of 46 cents​​ per share for the quarter ended September 30. The lone analyst forecast for the quarter was for a loss of 54 cents per share.

  • Revenue rose 3.2% to $15.15 million from a year ago; analysts expected $16.50 million.

  • Trinity Biotech PLC's reported EPS for the quarter was a loss of 46 cents​.

  • Trinity Biotech PLC shares had risen by 34.5% this quarter and lost 31.0% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 1.8% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

This summary was machine generated from LSEG data November 15 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2024

-0.54

-0.46

Beat

Jun. 30 2024

-0.65

-0.71

Missed

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10